Prevalence of Malignancies in Patients With Primary Aldosteronism

Katharina Lang; K Weber; M Quinkler; A S Dietz; H Wallaschofski; A Hannemann; N Friedrichs; L C Rump; B Heinze; C T Fuss; I Quack; H S Willenberg; M Reincke; B Allolio; S Hahner

doi:10.1210/jc.2015-3405

Prevalence of Malignancies in Patients With Primary Aldosteronism

Katharina Lang, K Weber, M Quinkler, A S Dietz, H Wallaschofski, A Hannemann, N Friedrichs, L C Rump, B Heinze, C T Fuss, I Quack, H S Willenberg, M Reincke, B Allolio, S Hahner

Metabolism and Systems Science

Research output: Contribution to journal › Article › peer-review

5 Citations (Scopus)

Abstract

In the multicenter MEPHISTO study, the prevalence of benign and malignant tumors has been investigated in 335 patients with confirmed primary aldosteronism and compared to matched controls. Compared to hypertensive controls, the prevalence of malignancies was positively correlated with aldosterone levels, tended to be higher in PA patients, but did not differ significantly.

Original language	English
Pages (from-to)	1656-63
Number of pages	8
Journal	The Journal of clinical endocrinology and metabolism
Volume	101
Issue number	4
Early online date	4 Feb 2016
DOIs	https://doi.org/10.1210/jc.2015-3405
Publication status	Published - Apr 2016

Keywords

Journal Article

Access to Document

10.1210/jc.2015-3405

Cite this

Lang, K., Weber, K., Quinkler, M., Dietz, A. S., Wallaschofski, H., Hannemann, A., Friedrichs, N., Rump, L. C., Heinze, B., Fuss, C. T., Quack, I., Willenberg, H. S., Reincke, M., Allolio, B., & Hahner, S. (2016). Prevalence of Malignancies in Patients With Primary Aldosteronism. The Journal of clinical endocrinology and metabolism, 101(4), 1656-63. https://doi.org/10.1210/jc.2015-3405

@article{884b06284f354d0d9bfb19ba5a47d6ba,

title = "Prevalence of Malignancies in Patients With Primary Aldosteronism",

abstract = "In the multicenter MEPHISTO study, the prevalence of benign and malignant tumors has been investigated in 335 patients with confirmed primary aldosteronism and compared to matched controls. Compared to hypertensive controls, the prevalence of malignancies was positively correlated with aldosterone levels, tended to be higher in PA patients, but did not differ significantly.",

keywords = "Journal Article",

author = "Katharina Lang and K Weber and M Quinkler and Dietz, {A S} and H Wallaschofski and A Hannemann and N Friedrichs and Rump, {L C} and B Heinze and Fuss, {C T} and I Quack and Willenberg, {H S} and M Reincke and B Allolio and S Hahner",

year = "2016",

month = apr,

doi = "10.1210/jc.2015-3405",

language = "English",

volume = "101",

pages = "1656--63",

journal = "The Journal of clinical endocrinology and metabolism",

issn = "0021-972X",

publisher = "Endocrine Society",

number = "4",

}

Lang, K, Weber, K, Quinkler, M, Dietz, AS, Wallaschofski, H, Hannemann, A, Friedrichs, N, Rump, LC, Heinze, B, Fuss, CT, Quack, I, Willenberg, HS, Reincke, M, Allolio, B & Hahner, S 2016, 'Prevalence of Malignancies in Patients With Primary Aldosteronism', The Journal of clinical endocrinology and metabolism, vol. 101, no. 4, pp. 1656-63. https://doi.org/10.1210/jc.2015-3405

TY - JOUR

T1 - Prevalence of Malignancies in Patients With Primary Aldosteronism

AU - Lang, Katharina

AU - Weber, K

AU - Quinkler, M

AU - Dietz, A S

AU - Wallaschofski, H

AU - Hannemann, A

AU - Friedrichs, N

AU - Rump, L C

AU - Heinze, B

AU - Fuss, C T

AU - Quack, I

AU - Willenberg, H S

AU - Reincke, M

AU - Allolio, B

AU - Hahner, S

PY - 2016/4

Y1 - 2016/4

N2 - In the multicenter MEPHISTO study, the prevalence of benign and malignant tumors has been investigated in 335 patients with confirmed primary aldosteronism and compared to matched controls. Compared to hypertensive controls, the prevalence of malignancies was positively correlated with aldosterone levels, tended to be higher in PA patients, but did not differ significantly.

AB - In the multicenter MEPHISTO study, the prevalence of benign and malignant tumors has been investigated in 335 patients with confirmed primary aldosteronism and compared to matched controls. Compared to hypertensive controls, the prevalence of malignancies was positively correlated with aldosterone levels, tended to be higher in PA patients, but did not differ significantly.

KW - Journal Article

U2 - 10.1210/jc.2015-3405

DO - 10.1210/jc.2015-3405

M3 - Article

C2 - 26844843

SN - 0021-972X

VL - 101

SP - 1656

EP - 1663

JO - The Journal of clinical endocrinology and metabolism

JF - The Journal of clinical endocrinology and metabolism

IS - 4

ER -

Prevalence of Malignancies in Patients With Primary Aldosteronism

Abstract

Keywords

Access to Document

Fingerprint

Cite this